Answers are grounded in this paper and cite their sources.
Case report shows successful radiotherapy and chemotherapy for pineoblastoma in a young adult, highlighting treatment strategies.
Pineoblastoma, a rare and aggressive embryonal tumour of the pineal region, predominantly affects children and young adults. It accounts for less than 1% of all central nervous system (CNS) tumours. These tumours, classified by the World Health Organization (WHO) as Grade IV pineal parenchymal tumours, are known for their rapid growth and tendency to spread via cerebrospinal fluid (CSF). Although histologically similar to medulloblastoma, Pineoblastoma has a more aggressive clinical behaviour. This report describes the successful management of an adult Pineoblastoma case. A 25-year-old male with symptoms of diplopia and headache was diagnosed with a pineal mass causing obstructive hydrocephalus. The patient had undergone endoscopic third ventriculostomy to relieve pressure symptoms followed by craniospinal irradiation (CSI) subsequently followed by chemotherapy. Radiotherapy was delivered using Helical Tomotherapy. Chemotherapy with Carboplatin and Etoposide was scheduled after radiotherapy, resulting in no residual tumour on follow-up imaging. The treatment strategy, including CSI and chemotherapy, aligns with current guidelines and offers insight into the management of Pineoblastoma in adults, where treatment protocols remain less standardized. The patient achieved significant recovery, with no signs of disease recurrence after two months. This case emphasizes the importance of personalized, treatment approaches and ongoing monitoring for this rare tumour
No takes yet. Share an insight, caveat, or question.
Choudhury et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: